The idea struck Robert Ietswaart, a research fellow in genetics at Harvard Medical School, while he was trying to determine how an experimental drug slowed the growth of lung cancer cells.
This Video Explains Cellular Compartmentation And Protein Sorting (Protein Transport in Mitochondria)
Thank You For Watching.
Please Like And Subscribe to Our Channel: https://www.youtube.com/EasyPeasyLearning.
Like Our Facebook Page: https://www.facebook.com/learningeasypeasy/
Join Our Facebook Group: https://www.facebook.com/groups/460057834950033
ABS is partnering with Telemedia, a broadcasting and teleport service provider in South Africa, to improve its service offerings to customers in the Middle East and Africa region (MEA). ABS announced Monday that the company will gain access to a full suite of telecom services provided by Telemedia at its Johannesburg teleport. Telemedia will provide teleport fiber connectivity, data center hosting, and satellite uplink capabilities.
Telemedia said the partnership enables the company to further expand its broadcast and satellite connectivity services in the MEA.
“Our collaboration with Telemedia reinforces and strengthens our presence in the MEA and provides an extension to our global connectivity network,” Ron Busch, ABS’ EVP Engineering and Operations said. “[Telemedia’s] infrastructure offering with a solid track record, excellent customer support and can-do attitude during the COVID-19 pandemic shows its commitment to excellent customer service.”
A first patient has been dosed in IMAC Holdings’ Phase 1 clinical trial evaluating its investigational umbilical cord-derived mesenchymal stem cells (MSCs) as a potential treatment for bradykinesia, a common motor symptom of Parkinson’s disease.
The infusion treatment was given on Dec. 292020, by the trial’s lead investigator Ricardo Knight, MD, at IMAC’s facility in Brentwood, Tennessee, the company announced.
These new, adaptive stem cells can lie dormant until needed, a new animal study using human cells shows.
A new type of stem cell – that is, a cell with regenerative abilities – could be closer on the horizon, a new study led by UNSW Sydney shows.
The stem cells (called induced multipotent stem cells, or iMS) can be made from easily accessible human cells – in this case, fat – and reprogrammed to act as stem cells.
MIT study sheds light on the longstanding question of why cancer cells get their energy from fermentation.
In the 1920s, German chemist Otto Warburg discovered that cancer cells don’t metabolize sugar the same way that healthy cells usually do. Since then, scientists have tried to figure out why cancer cells use this alternative pathway, which is much less efficient.
MIT biologists have now found a possible answer to this longstanding question. In a study appearing in Molecular Cell, they showed that this metabolic pathway, known as fermentation, helps cells to regenerate large quantities of a molecule called NAD+, which they need to synthesize DNA and other important molecules. Their findings also account for why other types of rapidly proliferating cells, such as immune cells, switch over to fermentation.